Position in VTRS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$11,481
-$30,183 QoQ
Shares Held
723
-76.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#751
of 1,016 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New Hampshire holds $328,632 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
526 | $285,002 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
711 | $12,307 | |
| 3 | VTRS |
Viatris Inc
This page
|
723 | $11,481 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
282 | $9,554 | |
| 5 | HROW |
Harrow, Inc.
|
190 | $8,069 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
110 | $2,219 |
All Filings in VTRS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,481 | 723 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $41,664 | 3,084 | Shares | Sole | 2026-04-13 | |
| 2022-12-31 | $1 | 16 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $1,397 | 164 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,146 | 205 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $2,350 | 216 | Shares | Sole | 2022-04-20 | |
| No filing history on record for this holder in this stock. | ||||||